The Germany-based pharma company Boehringer Ingelheim has experienced major growth in recent years, with 2020 net sales reaching EUR 19.6 billion. This expansion has been supported by increased reliance on real-world data (RWD) and real-world evidence (RWE) at every level of clinical […]
Arcadia and Datavant Announce New Partnership to Promote Real-World Data Platform
Datavant, leaders in connecting health data to organizations, and Arcadia, the healthcare data analytics platform, have announced a new partnership. The two companies will coordinate to bring Arcadia’s real-world data (RWD) offerings to life sciences and research organizations to promote health […]
AI for Mental Healthcare Must be Developed Carefully to Best Serve Patients
Artificial intelligence (AI) has risen into prominence in healthcare, providing patients and providers with helpful tools to improve healthcare outcomes. During the pandemic, mental healthcare saw increased adoption of AI solutions, but these tools are not fully matured and have notable issues that […]
Using Machine Learning to Investigate Long COVID
Many COVID-19 patients are experiencing lingering symptoms long after their initial infection has passed. Studying long COVID, as it is called, is complicated by the wide range of symptoms and lack of consensus of what constitutes the disorder. To address this issue, the National Institutes of […]
May 3rd – Webinar: The Convergence of Synthetic Data and Self-Service Analytics to Create a New RWE Model
Although real-world evidence (RWE) has had a massive impact on health sciences in recent years, obtaining enough high-quality real-world data (RWD) still remains a challenge. In an upcoming webinar on May 3rd, speakers will discuss how synthetic data can help fill the gaps and support advances in […]
ISPOR 2022: RWE Subprogram
The role of real-world data (RWD) and real-world evidence (RWE) in healthcare has grown in recent years as health economics and outcomes research (HEOR) experts have refined evidence generation and analysis methods. To help bring HEOR and other healthcare stakeholders up to speed, ISPOR is hosting […]
White Paper: Finland as a Real-World Evidence Resource
Finland has a long-running and well-established national health and social data system. This positions the nation as a rich resource for real-world evidence (RWE). In a new white paper, Business Finland explains the intricacies of the Finnish RWE ecosystem and how researchers and decision-makers […]
Webinar: Lessons Learned from Inspections and Audits During COVID-19
While the efforts and procedures of many regulatory bodies ground to a halt during the COVID-19 pandemic, the US Food and Drug Administration (FDA) pressed on with inspection. However, the agency’s tactics shifted as it adopted remote tools to connect with pharma and digital health companies before […]
Call for Abstracts and Reviewers: ISPOR Europe 2022
ISPOR is seeking abstracts for its upcoming ISPOR Europe 2022 conference. ISPOR Europe 2022 is the leading health economics and outcomes research (HEOR) conference in Europe, attracting professionals from academia, industry, and regulatory bodies. Poster and podium presentations are accepted. […]
Excelra Invests in Rising HEOR and RWE Consulting Firm Anlitiks
Excelra has announced a new majority investment in the health economics and outcomes research (HEOR) and real-world evidence (RWE) consulting firm Anlitik, located in Boston. The young company’s mission is to quickly process real-world data (RWD) into usable RWE for life sciences researchers and […]
